This is the authors' abstract. We don't add key points for this paper.
Background: Patients with upper gastrointestinal (UGI) cancers have historically poor survival.Improvement in surgical approaches and systemic therapies have increased UGI attendance at survivorship clinics.Methods: Prospective enrolment of patients attending the multidisciplinary Sydney Cancer Survivorship Centre (SCSC) clinic after curative intent treatment for UGI malignancies.Validated patient reported outcome measures for quality of life (QoL), symptom burden and lifestyle were collected.Clinical psychologist rated fear of cancer recurrence (FCR).Weights were collected from initial SCSC visit and 1 year follow-up, and compared to pre-treatment status.QoL was compared to general Australian population (T-score mean 50, SD 10).Results: Between 2015 and 2021, 48 survivors with gastric (57%), oesophageal (17%), biliary (13%) and pancreatic (11%) cancer were included.Median age 62 years (IQR 57-71); 56% male.Treatment included surgery (98%), chemotherapy (83%), radiotherapy (6%).Median time to initial SCSC visit was 12 months (IQR 9.4-13.7).Mean weight at initial SCSC clinic was 5.7 kg (SD 8.2) lower than pretreatment.Obese or overweight survivors accounted for 47% at initial review and 48% at follow-up.At initial review, aerobic and resistance exercise guidelines were achieved by 13% and 10%, respectively.At 12-month follow-up, 16% achieved both exercise recommendations.In total, ≥5 symptoms of at least moderate severity (4+/10) at initial and follow-up reviews were experienced by 43% and 38%, respectively.The most common symptoms were pain, fatigue, anorexia, trouble sleeping and numbness.Mean QoL scores were lowest in physical (T-score 44.4) and emotional well-being (T-score 43.8) domains.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: